Early Postoperative Safety of Total Hip Arthroplasty in Systemic Lupus Erythematosus Patients
ObjectiveTo analyze the occurrence of early complications after total hip arthroplasty (THA) in patients with systemic lupus erythematosus (SLE).MethodsThe data of patients who underwent THA at Peking Union Medical College Hospital from June 2012 to April 2024 were retrospectively and consecutively...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of Medical Journal of Peking Union Medical College Hospital
2025-01-01
|
| Series: | Xiehe Yixue Zazhi |
| Subjects: | |
| Online Access: | https://xhyxzz.pumch.cn/article/doi/10.12290/xhyxzz.2024-0856 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1823865205841461248 |
|---|---|
| author | YANG Xingdong YU Muyang XU Yiming ZHU Wei HU Mingwei WENG Xisheng FENG Bin |
| author_facet | YANG Xingdong YU Muyang XU Yiming ZHU Wei HU Mingwei WENG Xisheng FENG Bin |
| author_sort | YANG Xingdong |
| collection | DOAJ |
| description | ObjectiveTo analyze the occurrence of early complications after total hip arthroplasty (THA) in patients with systemic lupus erythematosus (SLE).MethodsThe data of patients who underwent THA at Peking Union Medical College Hospital from June 2012 to April 2024 were retrospectively and consecutively collected. The patients were categorized into SLE group and control group based on the presence or absence of SLE. Using propensity score matching, we matched patients in the two groups at a 1∶1 ratio according to gender, age, and surgical side. Subsequently, we compared the clinical characteristics, incidence of major complications within 30 days postoperatively, and allogeneic blood transfusion rates between the two groups.ResultsA total of 270 patients in the SLE group who met the inclusion and exclusion criteria were selected. Within 30 days postoperatively, 18 cases (6.67%) experienced major complications, including 2 cases (0.74%) of upper respiratory tract infection, 2 cases (0.74%) of pulmonary infection, 3 cases (1.11%) of urinary tract infection, 2 cases (0.74%) of other systemic infection, 5 cases (1.85%) of poor wound healing, 1 case (0.37%) of wound infection, 1 case (0.37%) of gastrointestinal complications, 1 cases (0.37%) of shock, and 1 case (0.37%) of SLE flare-up. The allogeneic blood transfusion rate was 22.59% (61/270). After propensity score matching, 163 cases from SLE and control groups were included for analysis. (1) Regarding medical complications, compared with control group, SLE group showed significant differences in osteoporosis, respiratory system disorders, gastrointestinal diseases, urinary system disorders, hematologic abnormalities, and secondary or concomitant rheumatic diseases (all P < 0.05). (2) In terms of preoperative laboratory tests, SLE group had lower platelet counts, absolute lymphocyte counts, hemoglobin levels, hematocrit, albumin levels, blood glucose levels, and activated partial thromboplastin times than control group, while C-reactive protein, erythrocyte sedimentation rate, and D-dimer levels were higher (all P < 0.05). (3) Regarding surgical-related indicators, a higher proportion of patients in SLE group had an ASA grade > 2 (15.95% vs. 3.07%, P < 0.001), but intraoperative blood loss was significantly smaller [324.7 (200.0, 500.0) mL vs. 421.8 (200.0, 500.0) mL, P=0.005]. (4) In terms of complications, SLE group exhibited a significantly higher incidence of major complications than control group (8.59% vs. 1.23%, P=0.005), with a relative risk of 1.081 (95% CI: 1.028-1.136). No significant difference was observed in the allogeneic blood transfusion rate between SLE group and control group (25.77% vs. 17.18%, P=0.059).ConclusionsThe incidence of major complications within 30 days following THA in patients with SLE was significantly higher than that in non-SLE patients, while the rate of allogeneic blood transfusion remained comparable. To ensure the safety of THA surgery for patients with SLE, it is important to optimize the patient's condition and achieve stabilization prior to surgery. Additionally, strict perioperative management must be forced. |
| format | Article |
| id | doaj-art-24368fdaaf9546ca9cd2577435e8ffb6 |
| institution | Kabale University |
| issn | 1674-9081 |
| language | zho |
| publishDate | 2025-01-01 |
| publisher | Editorial Office of Medical Journal of Peking Union Medical College Hospital |
| record_format | Article |
| series | Xiehe Yixue Zazhi |
| spelling | doaj-art-24368fdaaf9546ca9cd2577435e8ffb62025-02-08T07:47:34ZzhoEditorial Office of Medical Journal of Peking Union Medical College HospitalXiehe Yixue Zazhi1674-90812025-01-01161424910.12290/xhyxzz.2024-0856Early Postoperative Safety of Total Hip Arthroplasty in Systemic Lupus Erythematosus PatientsYANG XingdongYU MuyangXU Yiming0ZHU Wei1HU MingweiWENG Xisheng2FENG Bin3Department of Orthopedics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, ChinaDepartment of Orthopedics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, ChinaDepartment of Orthopedics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, ChinaDepartment of Orthopedics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, ChinaObjectiveTo analyze the occurrence of early complications after total hip arthroplasty (THA) in patients with systemic lupus erythematosus (SLE).MethodsThe data of patients who underwent THA at Peking Union Medical College Hospital from June 2012 to April 2024 were retrospectively and consecutively collected. The patients were categorized into SLE group and control group based on the presence or absence of SLE. Using propensity score matching, we matched patients in the two groups at a 1∶1 ratio according to gender, age, and surgical side. Subsequently, we compared the clinical characteristics, incidence of major complications within 30 days postoperatively, and allogeneic blood transfusion rates between the two groups.ResultsA total of 270 patients in the SLE group who met the inclusion and exclusion criteria were selected. Within 30 days postoperatively, 18 cases (6.67%) experienced major complications, including 2 cases (0.74%) of upper respiratory tract infection, 2 cases (0.74%) of pulmonary infection, 3 cases (1.11%) of urinary tract infection, 2 cases (0.74%) of other systemic infection, 5 cases (1.85%) of poor wound healing, 1 case (0.37%) of wound infection, 1 case (0.37%) of gastrointestinal complications, 1 cases (0.37%) of shock, and 1 case (0.37%) of SLE flare-up. The allogeneic blood transfusion rate was 22.59% (61/270). After propensity score matching, 163 cases from SLE and control groups were included for analysis. (1) Regarding medical complications, compared with control group, SLE group showed significant differences in osteoporosis, respiratory system disorders, gastrointestinal diseases, urinary system disorders, hematologic abnormalities, and secondary or concomitant rheumatic diseases (all P < 0.05). (2) In terms of preoperative laboratory tests, SLE group had lower platelet counts, absolute lymphocyte counts, hemoglobin levels, hematocrit, albumin levels, blood glucose levels, and activated partial thromboplastin times than control group, while C-reactive protein, erythrocyte sedimentation rate, and D-dimer levels were higher (all P < 0.05). (3) Regarding surgical-related indicators, a higher proportion of patients in SLE group had an ASA grade > 2 (15.95% vs. 3.07%, P < 0.001), but intraoperative blood loss was significantly smaller [324.7 (200.0, 500.0) mL vs. 421.8 (200.0, 500.0) mL, P=0.005]. (4) In terms of complications, SLE group exhibited a significantly higher incidence of major complications than control group (8.59% vs. 1.23%, P=0.005), with a relative risk of 1.081 (95% CI: 1.028-1.136). No significant difference was observed in the allogeneic blood transfusion rate between SLE group and control group (25.77% vs. 17.18%, P=0.059).ConclusionsThe incidence of major complications within 30 days following THA in patients with SLE was significantly higher than that in non-SLE patients, while the rate of allogeneic blood transfusion remained comparable. To ensure the safety of THA surgery for patients with SLE, it is important to optimize the patient's condition and achieve stabilization prior to surgery. Additionally, strict perioperative management must be forced.https://xhyxzz.pumch.cn/article/doi/10.12290/xhyxzz.2024-0856systemic lupus erythematosusavascular necrosis of the femoral headtotal hip replacementpostoperative complications |
| spellingShingle | YANG Xingdong YU Muyang XU Yiming ZHU Wei HU Mingwei WENG Xisheng FENG Bin Early Postoperative Safety of Total Hip Arthroplasty in Systemic Lupus Erythematosus Patients Xiehe Yixue Zazhi systemic lupus erythematosus avascular necrosis of the femoral head total hip replacement postoperative complications |
| title | Early Postoperative Safety of Total Hip Arthroplasty in Systemic Lupus Erythematosus Patients |
| title_full | Early Postoperative Safety of Total Hip Arthroplasty in Systemic Lupus Erythematosus Patients |
| title_fullStr | Early Postoperative Safety of Total Hip Arthroplasty in Systemic Lupus Erythematosus Patients |
| title_full_unstemmed | Early Postoperative Safety of Total Hip Arthroplasty in Systemic Lupus Erythematosus Patients |
| title_short | Early Postoperative Safety of Total Hip Arthroplasty in Systemic Lupus Erythematosus Patients |
| title_sort | early postoperative safety of total hip arthroplasty in systemic lupus erythematosus patients |
| topic | systemic lupus erythematosus avascular necrosis of the femoral head total hip replacement postoperative complications |
| url | https://xhyxzz.pumch.cn/article/doi/10.12290/xhyxzz.2024-0856 |
| work_keys_str_mv | AT yangxingdong earlypostoperativesafetyoftotalhiparthroplastyinsystemiclupuserythematosuspatients AT yumuyang earlypostoperativesafetyoftotalhiparthroplastyinsystemiclupuserythematosuspatients AT xuyiming earlypostoperativesafetyoftotalhiparthroplastyinsystemiclupuserythematosuspatients AT zhuwei earlypostoperativesafetyoftotalhiparthroplastyinsystemiclupuserythematosuspatients AT humingwei earlypostoperativesafetyoftotalhiparthroplastyinsystemiclupuserythematosuspatients AT wengxisheng earlypostoperativesafetyoftotalhiparthroplastyinsystemiclupuserythematosuspatients AT fengbin earlypostoperativesafetyoftotalhiparthroplastyinsystemiclupuserythematosuspatients |